Escape From Tarkov 1.0 has now been here for a week, and it's gone about as I expected. It might have been one of the first FPS games to lock down what's now become the hyper-popular extraction ...

The U.S. Department of Energy said Tuesday that it will loan $1 billion to help finance the restart of the nuclear power plant on Pennsylvania's Three Mile Island that is under contract to supply ...

The Trump administration said Tuesday that it is providing a $1 billion loan to Constellation Energy to help restart the nuclear reactor at the former Three Mile Island plant in Pennsylvania.

The Pennsylvania site, shorthand for the dangers of nuclear power after a 1979 meltdown, is set for revival under a deal to power Microsoft data centers. By Qasim Nauman The Trump administration is ...

WASHINGTON, Nov 18 (Reuters) - The Trump administration said on Tuesday it has loaned Constellation Energy Corp (CEG.O), opens new tab $1 billion to restart its nuclear reactor at a Pennsylvania plant ...

The owner of the shuttered Three Mile Island nuclear plant has been awarded a $1 billion federal loan guarantee that will enable it to shift onto taxpayers some of the risk of its plan to restart the ...

The Trump administration said on Tuesday it has loaned Constellation Energy Corp $1 billion to restart its nuclear reactor at a Pennsylvania plant formerly known as Three Mile Island. Constellation ...

Deepwatch, a cybersecurity firm that makes an AI-powered detection and response platform, laid off dozens of employees on Wednesday, citing AI as one of the reasons. John DiLullo, CEO at Deepwatch, ...

The PGA Tour is in Los Cabos, Mexico, for this week’s World Wide Technology Championship, the fifth of seven FedExCup Fall events. Here’s a look at first-round tee times and groupings on El Cardonal ...

The World Wide Technology Championship takes place at El Cardonal at Diamante in Los Cabos, Mexico, and features a $6 million purse. The 7,452-yard, par-72 course returns as host. Austin Eckroat won ...

TScan Therapeutics is laying off 30% of its workforce as the T-cell receptor (TCR) therapy biotech abandons a phase 1 solid tumor trial and focuses on patients with blood cancers. The company had ...